RPG Life Sciences - Quaterly Results

17 Oct 2022 Evaluate
The Revenue for the quarter ended  September 2022 of Rs. 1347.90 millions grew by 19.65 % from Rs. 1126.50 millions.Good  Net Profit growth of 26.79% reported above the corresponding previous quarter figure of Rs. 157.50 millions to Rs. 199.70 millioins.Operating profit surged to 309.60 millions from the corresponding previous quarter of 265.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1347.90 1126.50 19.65 2637.20 2207.80 19.45 4401.60 3891.40 13.11
Other Income 12.30 7.10 73.24 24.50 11.20 118.75 29.90 9.10 228.57
PBIDT 309.60 265.10 16.79 600.20 498.70 20.35 893.50 708.40 26.13
Interest 0.80 1.70 -52.94 1.90 3.00 -36.67 5.20 7.90 -34.18
PBDT 308.80 263.40 17.24 598.30 495.70 20.70 888.30 700.50 26.81
Depreciation 38.70 39.90 -3.01 77.00 79.50 -3.14 156.60 164.70 -4.92
PBT 270.10 223.50 20.85 521.30 416.20 25.25 731.70 535.80 36.56
TAX 70.40 66.00 6.67 139.50 122.90 13.51 216.90 135.80 59.72
Deferred Tax -1.20 -1.00 20.00 2.10 -1.90 -210.53 -10.70 -35.70 -70.03
PAT 199.70 157.50 26.79 381.80 293.30 30.17 514.80 400.00 28.70
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 22.97 23.53 -2.40 22.76 22.59 0.76 20.30 18.20 11.51

RPG Life Sciences Share Price

2035.15 -8.20 (-0.40%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.